Tachylectin-2 Antibody

What is Tachylectin-2 and why is it significant for immunological research?

Tachylectin-2 is a 236 amino acid lectin protein isolated from large granules of hemocytes in the Japanese horseshoe crab (Tachypleus tridentatus). Its significance stems from its role in the innate immunity host defense system, specifically through its ability to bind to N-acetylglucosamine and N-acetylgalactosamine . The protein is particularly noteworthy for being the first discovered protein with a five-bladed β-propeller structure, where five four-stranded antiparallel β-sheets with W-like topology arrange around a central water-filled tunnel .

This structural uniqueness, combined with its specific binding properties, makes Tachylectin-2 an excellent model for studying carbohydrate recognition in innate immunity. The protein's five virtually identical binding sites suggest it functions by recognizing carbohydrate surface structures on pathogens with high ligand density, employing both specificity for certain N-acetyl sugars and surface ligand density for self/non-self recognition . This mechanism represents a fundamental aspect of primitive immune systems that predates adaptive immunity.

How does Tachylectin-2 differ from other lectins in the horseshoe crab immune system?

Tachylectin-2 is part of a family of lectins (tachylectins 1-4) stored in horseshoe crab hemocytes, each with distinct specificities and functions within the immune response. Unlike its family members, Tachylectin-2 shows no significant sequence similarity to any other known protein, including other tachylectins .

The key differences between these tachylectins include:

Unlike the more promiscuous Tachylectin-1, which broadly recognizes both Gram-positive and Gram-negative bacteria, Tachylectin-2 displays a highly specialized recognition pattern, binding only to specific Staphylococcus species with GlcNAc-substituted LTA . This suggests that Tachylectin-2 complements broader-spectrum immune proteins by providing highly specialized recognition capabilities.

What are the specific structural features of Tachylectin-2's binding sites and how do they influence antibody design?

Tachylectin-2's binding sites have several distinctive structural characteristics that directly impact antibody design strategies. The protein exhibits five virtually identical binding sites, one in each β-sheet of its five-bladed β-propeller structure . These binding sites are positioned between adjacent β-sheets and formed by a large loop between the outermost strands of the β-sheets and the connecting segment from the previous β-sheet .

The molecular architecture of each binding site includes:

• A central cavity accommodating the N-acetyl group and hydroxyl groups of bound sugars

• Critical hydrogen bonding networks involving conserved amino acid residues

• Specific orientation requirements for the 4-OH group of binding partners

The configuration of C4 with a 4-OH group trans to CH2OH (equatorial 4-OH) in GlcNAc leads to an association constant 17-fold higher than that for GalNAc, which has a cis 4-OH group (axial 4-OH) . This binding preference demonstrates the remarkable specificity of the recognition system.

When designing antibodies against Tachylectin-2, researchers must consider these structural features, particularly when targeting epitopes near binding sites. Antibodies that preserve the native conformation of these sites would be essential for functional studies, while those that potentially block these sites could serve as experimental tools to probe Tachylectin-2's role in pathogen recognition.

How does the pentameric arrangement of Tachylectin-2's binding domains affect its functional properties?

The pentameric arrangement of Tachylectin-2's binding domains creates a unique functional profile that directly impacts its biological activity. The five-fold symmetry of the protein results in a pentagonal torus shape with approximately 25 Å height and 45-48 Å diameter, with five binding sites arranged with pseudo-symmetry around a central tunnel .

This arrangement has several important functional implications:

• Multivalent binding capability: The five binding sites allow simultaneous interaction with multiple carbohydrate epitopes on pathogen surfaces, significantly enhancing avidity through the "cluster effect" .

• Spatial optimization: The 72° rotation between adjacent β-sheets (compared to 90° in 4-fold and smaller angles in higher-fold symmetry propellers) creates optimal spacing for recognizing patterns of GlcNAc/GalNAc residues commonly found on bacterial surfaces .

• Structural stability: The unique ring of conserved phenylalanine residues anchored in the innermost strand of each β-sheet contributes to structural integrity, unlike other β-propellers that typically have small side chains near the central tunnel .

• Ligand density discrimination: The spatial arrangement enables Tachylectin-2 to distinguish self from non-self based not only on carbohydrate composition but also on the density of target epitopes - a critical parameter in innate immunity .

These structural features collectively enable Tachylectin-2 to function effectively as a pattern recognition receptor that specifically targets microbial surface carbohydrates while avoiding interaction with host tissues, even though similar carbohydrate structures may be present in both contexts at different densities or conformations.

What are the most effective methods for producing and purifying Tachylectin-2 antibodies for research?

While the search results don't specifically address antibody production against Tachylectin-2, we can derive methodological approaches based on the protein's characteristics described in the data:

• Antigen preparation strategies:

  • Using recombinant Tachylectin-2 expressed in bacterial systems, taking advantage of the known 236 amino acid sequence

  • Generating peptide antigens based on regions outside the conserved binding sites to avoid interference with functional studies

  • Creating fusion proteins that preserve the native pentameric structure, essential for conformational epitopes

• Purification methods:

  • Affinity chromatography using immobilized GlcNAc/GalNAc ligands could be used both for purifying Tachylectin-2 and subsequently for purifying antibodies through antigen columns

  • Ion exchange chromatography taking advantage of Tachylectin-2's charge properties

  • Size exclusion chromatography to separate antibody fractions from other serum components

• Validation techniques:

  • ELISA assays using purified Tachylectin-2 to confirm binding

  • Western blot analysis to verify specificity

  • Immunoprecipitation followed by mass spectrometry to confirm target identity

  • Functional inhibition assays measuring the antibody's ability to block Tachylectin-2's hemagglutination activity with human A-type erythrocytes

What experimental protocols can be used to evaluate Tachylectin-2 antibody specificity and cross-reactivity?

Evaluating antibody specificity and cross-reactivity for Tachylectin-2 requires protocols that address its unique structural and functional properties:

• Cross-reactivity assessment with other tachylectins:

  • Western blot analysis against tachylectins 1, 3, and 4 to assess potential cross-reactivity

  • Competitive binding assays to determine if the antibody can distinguish between different tachylectins

  • Immunohistochemistry on horseshoe crab tissues expressing multiple tachylectins

• Functional inhibition assays:

  • Hemagglutination inhibition assays with human A-type erythrocytes, which Tachylectin-2 is known to agglutinate

  • Bacterial agglutination assays using Staphylococcus saprophyticus KD, which carries the α(1–2)‐linked GlcNAc that Tachylectin-2 recognizes

  • Carbohydrate binding inhibition assays using GlcNAc, GalNAc, and more complex oligosaccharides

• Structural verification methods:

  • Circular dichroism spectroscopy to assess if antibody binding affects the secondary structure

  • Surface plasmon resonance to measure binding kinetics and affinity

  • X-ray crystallography of antibody-Tachylectin-2 complexes to determine binding epitopes

• Epitope mapping protocols:

  • Peptide arrays covering the entire Tachylectin-2 sequence

  • Hydrogen-deuterium exchange mass spectrometry to identify antibody binding regions

  • Site-directed mutagenesis of key residues followed by binding assays

These methods should account for the pentameric structure of Tachylectin-2 and the presence of five virtually identical binding sites, which may create challenges for antibody specificity testing.

How can Tachylectin-2 antibodies be used to study innate immunity mechanisms?

Tachylectin-2 antibodies offer valuable tools for investigating innate immunity mechanisms, particularly in invertebrate systems and evolutionary immunology:

The unique binding specificity of Tachylectin-2 for GlcNAc/GalNAc with free 4-OH groups, combined with its inability to bind to β-1,4-linked GlcNAc units of chitin (except terminal units) , makes it an excellent model for studying how innate immune proteins distinguish self from non-self through specific carbohydrate recognition patterns.

What are the potential applications of Tachylectin-2 antibodies in pathogen detection and immunity studies?

Tachylectin-2 antibodies have several promising applications in pathogen detection and immunity research:

• Pathogen detection systems:

  • Development of sandwich ELISA systems using Tachylectin-2 for capturing pathogens and anti-Tachylectin-2 antibodies for detection

  • Biosensors incorporating immobilized Tachylectin-2 with antibody-based detection systems

  • Flow cytometry applications for bacterial identification using Tachylectin-2's binding specificity

• Mechanism of action studies:

  • Investigation of Tachylectin-2's proposed mechanisms including agglutination, opsonization, and surface blocking

  • Antibody-based inhibition studies to determine which mechanism predominates in different contexts

  • Structure-function relationship studies using antibodies that target specific domains

• Comparative immunology applications:

  • Assessment of whether Tachylectin-2-like proteins exist in other organisms using cross-reactive antibodies

  • Evolutionary studies of carbohydrate-binding pattern recognition receptors

  • Investigation of convergent evolution in innate immunity

• Therapeutic research:

  • Development of antimicrobial strategies based on Tachylectin-2's binding mechanisms

  • Investigation of similar recognition systems in vertebrate immunity

  • Design of recognition molecules that mimic Tachylectin-2's specificity

Given Tachylectin-2's highly specific binding to GlcNAc-substituted lipoteichoic acid on Staphylococcus saprophyticus and its lack of binding to other bacteria such as Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus luteus, Enterococcus hirae, and Escherichia coli , antibodies against this protein could be valuable tools for studying specialized pathogen recognition mechanisms.

How does the five-bladed β-propeller structure of Tachylectin-2 impact antibody binding and epitope accessibility?

The five-bladed β-propeller structure of Tachylectin-2 creates unique considerations for antibody binding and epitope accessibility:

• Structural symmetry considerations:

  • The five virtually identical β-sheets arranged with 5-fold pseudosymmetry around a central tunnel may present similar epitopes in multiple locations

  • Each β-sheet contains four antiparallel β-strands with W-like topology, creating repetitive structural motifs

  • The 47-residue tandem repeats with 49-68% internal sequence identity may create cross-reactive epitopes

• Accessible vs. hidden epitopes:

  • The flat pentagonal torus shape (height ~25 Å, diameter ~45-48 Å) presents large accessible surfaces on both faces

  • The central water-filled tunnel (7-8 Å diameter) is likely inaccessible to antibodies

  • The binding sites located between adjacent β-sheets may be partially occluded when occupied by ligands

• Conformational considerations:

  • The conserved phenylalanine residues anchored in the innermost strand of each β-sheet contribute to structural stability

  • Large spatial gaps between adjacent β-sheets (due to the 72° rotation angle in 5-fold symmetry) may create unique conformational epitopes

  • The 3→4 loop of each β-sheet and connecting segments between β-sheets fill these gaps and may be particularly accessible to antibodies

The unique pentameric structure creates both challenges and opportunities for antibody development - while the repetitive nature may complicate specificity, the distinctive structural features also provide targets for highly specific antibody recognition.

What controls should be incorporated when using Tachylectin-2 antibodies in research protocols?

When designing experiments with Tachylectin-2 antibodies, researchers should implement several critical controls to ensure data validity:

• Specificity controls:

  • Pre-absorption controls using purified recombinant Tachylectin-2 to confirm signal specificity

  • Testing against other tachylectins (1, 3, 4) to verify lack of cross-reactivity

  • Comparison with pre-immune serum or isotype controls for monoclonal antibodies

  • Testing in tissues/samples known to be negative for Tachylectin-2

• Functional validation controls:

  • Parallel hemagglutination assays with human A-type erythrocytes

  • Bacterial agglutination assays with Staphylococcus saprophyticus KD

  • Sugar inhibition studies using GlcNAc and GalNAc to confirm binding site specificity

  • Comparison of binding parameters with the established properties of Tachylectin-2

• Structural integrity controls:

  • Circular dichroism to confirm that antibody binding doesn't disrupt the β-propeller structure

  • Size exclusion chromatography to verify the pentameric state is maintained

  • Thermal shift assays to assess stability of the antibody-antigen complex

• Technical controls:

  • Concentration-matched non-specific antibodies to control for background binding

  • Blocking peptide competition assays to confirm epitope specificity

  • Multiple antibody clones targeting different epitopes to validate observations

  • Recombinant expression of Tachylectin-2 in knockout/negative systems as positive controls

These controls address the unique structural and functional properties of Tachylectin-2, particularly its pentameric arrangement with five virtually identical binding sites and its highly specific carbohydrate recognition profile.